Josef Vymazal, MD

Articles by Josef Vymazal, MD

Why MRI Contrast Agents Are Not Interchangeable for Detecting Brain Metastases

September 9th 2026

Josef Vymazal, MD, explained why high-relaxivity contrast agents are critical for detecting small brain metastases, despite weaker agents remaining suitable for other indications.

Latest Updated Articles

Trending on CancerNetwork

FDA Withdraws Adagrasib/Cetuximab Approval in KRAS G12C-Mutated CRC

FDA Gives Accelerated Approval to Sevabertinib in HER2+ NSCLC

Enrollment Begins for Elritercept Phase 3 Trial in Lower-Risk MDS

Azacitidine/Venetoclax Boosts Event-Free Survival in Induction-Eligible AML

Goal-Based Nutrition Support May Not Limit Muscle Loss in Esophageal Cancer